Post-Surgery Circulating Tumor Cells and AXL Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma

Axl kinase drives immune checkpoint and chemokine signalling pathways in lung adenocarcinomas

(2019) Yoko Tsukita et al.   Molecular Cancer

The Roles of MicroRNA in Lung Cancer

(2019) Kuan-Li Wu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

PD-L1 Expression with Epithelial Mesenchymal Transition of Circulating Tumor Cells Is Associated with Poor Survival in Curatively Resected Non-Small Cell Lung Cancer

(2019) Yariswamy Manjunath et al.   Cancers

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

(2018) Patrick M. Forde et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tumor Mutation Burden as a Biomarker in Resected Non–Small-Cell Lung Cancer

(2018) Siddhartha Devarakonda et al.   JOURNAL OF CLINICAL ONCOLOGY

New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer

(2018) Anushka Dongre et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Association of circulating tumour cells with early relapse and 18F-fluorodeoxyglucose positron emission tomography uptake in resected non-small-cell lung cancers†

(2017) Clara I. Bayarri-Lara et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update

(2017) Mark G. Kris et al.   JOURNAL OF CLINICAL ONCOLOGY

Tracking the Evolution of Non–Small-Cell Lung Cancer

(2017) Mariam Jamal-Hanjani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Correlation between the presence of circulating tumor cells and the pathologic type and staging of non-small cell lung cancer during the early postoperative period

(2017) Zhanqiang Xie et al.   Oncology Letters

PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system?

(2017) Cristina Raimondi et al.   OncoImmunology

Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature

(2016) A.J. van der -->Wekken et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Glyceraldehyde-3-phosphate dehydrogenase promotes cancer growth and metastasis through upregulation of SNAIL expression

(2016) Kaiyan Liu et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas

(2016) Joshua D Campbell et al.   NATURE GENETICS

Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection

(2016) Clara Bayarri-Lara et al.   PLoS One

Reprogramming the immunological microenvironment through radiation and targeting Axl

(2016) Todd A. Aguilera et al.   Nature Communications

MicroRNAs as Regulators of Cisplatin Resistance in Lung Cancer

(2015) Ying Chen et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Epithelial-Mesenchymal Transitioned Circulating Tumor Cells Capture for Detecting Tumor Progression

(2014) A. Satelli et al.   CLINICAL CANCER RESEARCH

Therapeutic uses of anti-interleukin-6 receptor antibody

(2014) S. Kang et al.   INTERNATIONAL IMMUNOLOGY

JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells

(2014) RENG-YUN LIU et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Early Stage Lung Cancer: Progress in the Last 40 Years

(2014) Silvia Novello et al.   Journal of Thoracic Oncology

Clinical relevance of circulating cell-free microRNAs in cancer

(2014) Heidi Schwarzenbach et al.   Nature Reviews Clinical Oncology

Therapeutic Use of MicroRNAs in Lung Cancer

(2014) Orazio Fortunato et al.   Biomed Research International

Cisplatin influences acquisition of resistance to molecular-targeted agents through epithelial-mesenchymal transition-like changes

(2013) Maki Kurokawa et al.   CANCER SCIENCE

Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies

(2013) Rosa Nadal et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

The Role of miRNAs in Regulating Gene Expression Networks

(2013) Allan M. Gurtan et al.   JOURNAL OF MOLECULAR BIOLOGY

Glyceraldehyde-3-phosphate dehydrogenase gene over expression correlates with poor prognosis in non small cell lung cancer patients

(2013) Roberto Puzone et al.   Molecular Cancer

Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis

(2013) Ana Barradas et al.   Cancers

Higher Expression of Receptor Tyrosine Kinase Axl, and Differential Expression of its Ligand, Gas6, Predict Poor Survival in Lung Adenocarcinoma Patients

(2012) Masashi Ishikawa et al.   ANNALS OF SURGICAL ONCOLOGY

Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization

(2012) Jan Budczies et al.   PLoS One

Differences Between Squamous Cell Carcinoma and Adenocarcinoma of the Lung: Are Adenocarcinoma and Squamous Cell Carcinoma Prognostically Equal?

(2011) A. Kawase et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method

(2010) Véronique Hofman et al.   INTERNATIONAL JOURNAL OF CANCER

Analyzing real-time PCR data by the comparative CT method

(2008) Thomas D Schmittgen et al.   Nature Protocols